The subject application is related a co-pending and commonly-owned application filed on even date herewith, the disclosure of which is hereby incorporated by reference in its entirety, the application being respectively entitled Ultrasonic Surgical Instruments to Foster B. Stulen, application Ser. No. 11/881,636, now U.S. Patent Application Publication No. 2009/0030438.
Ultrasonic instruments, including both hollow core and solid core instruments, are used for the safe and effective treatment of many medical conditions. Ultrasonic instruments, and particularly solid core ultrasonic instruments, are advantageous because they may be used to cut and/or coagulate tissue using energy in the form of mechanical vibrations transmitted to a surgical end effector at ultrasonic frequencies. Ultrasonic vibrations, when transmitted to organic tissue at suitable energy levels and using a suitable end effector, may be used to cut, dissect, or coagulate tissue or elevate or separate muscle tissue off bone. Ultrasonic instruments utilizing solid core technology are particularly advantageous because of the amount of ultrasonic energy that may be transmitted from the ultrasonic transducer, through an ultrasonic transmission waveguide, to the surgical end effector. Such instruments may be used for open procedures or minimally invasive procedures, such as endoscopic or laparoscopic procedures, wherein the end effector is passed through a trocar to reach the surgical site.
Activating or exciting the single or multiple element end effector (e.g., cutting blade, ball coagulator) of such instruments at ultrasonic frequencies induces longitudinal, transverse, or torsional vibratory movement that generates localized heat within adjacent tissue, facilitating both cutting and coagulating. Because of the nature of ultrasonic instruments, a particular ultrasonically actuated end effector may be designed to perform numerous functions, including, for example, cutting and coagulating.
Ultrasonic vibration is induced in the surgical end effector by electrically exciting a transducer, for example. The transducer may be constructed of one or more piezoelectric or magnetostrictive elements in the instrument hand piece. Vibrations generated by the transducer section are transmitted to the surgical end effector via an ultrasonic waveguide extending from the transducer section to the surgical end effector. The waveguides and end effectors are most preferably designed to resonate at the same frequency as the transducer. When an end effector is attached to a transducer the overall system frequency may be the same frequency as the transducer itself.
The transducer and the end effector may be designed to resonate at two different frequencies and when joined or coupled may resonate at a third frequency. The zero-to-peak amplitude of the longitudinal ultrasonic vibration at the tip, d, of the end effector behaves as a simple sinusoid at the resonant frequency as given by:
d=A sin(ωt)
where:
ω=the radian frequency which equals 2π times the cyclic frequency, f; and
A=the zero-to-peak amplitude.
The longitudinal excursion is defined as the peak-to-peak (p-t-p) amplitude, which is just twice the amplitude of the sine wave or 2 A.
Solid core ultrasonic surgical instruments may be divided into two types, single element end effector devices and multiple-element end effectors. Single element end effector devices include instruments such as scalpels (e.g., blades, sharp hook blades, dissecting hook blades, curved blades) and ball coagulators. Single-element end effector instruments have limited ability to apply blade-to-tissue pressure when the tissue is soft and loosely supported. Substantial pressure may be necessary to effectively couple ultrasonic energy to the tissue. The inability of a single-element end effector to grasp the tissue results in a further inability to fully coapt tissue surfaces while applying ultrasonic energy, leading to less-than-desired hemostasis and tissue joining. The use of multiple-element end effectors such as clamping coagulators includes a mechanism to press tissue against an ultrasonic blade that can overcome these deficiencies.
Ultrasonic clamp coagulators or clamped coagulating shears provide an improved ultrasonic surgical instrument for cutting/coagulating tissue, particularly loose and unsupported tissue, wherein the ultrasonic blade is employed in conjunction with a clamp for applying a compressive or biasing force to the tissue, whereby faster coagulation and cutting of the tissue.
As the distal end of the end effector, or more particularly, the blade, cuts through or coagulates tissue it comes into contact with fluid (e.g., blood, tissue particles). When the distal end of the blade contacts this fluid, a fine mist in the form of a diverging plume of fluid particles may emanate from the distal end of the blade. This plume of mist may limit visibility at the surgical site. It would be desirable to provide an ultrasonic instrument which reduces the plume of mist emanating from the distal end of the end effector.
In one general aspect, the various embodiments are directed to a surgical instrument with mist reducing features. The surgical instrument may comprise a transducer configured to produce vibrations at a predetermined frequency. An ultrasonic blade extends along a longitudinal axis and is coupled to the transducer. The ultrasonic blade comprises a body without a channel, and the body comprises a proximal end and a distal end. The distal end is movable relative to the longitudinal axis by the vibrations produced by the transducer. At least a portion of the body comprises at least one layer of a first material to globalize fluid particles in contact therewith.
In other embodiments, the body may also comprise additional elements which may lead to the reduction of mist. In one embodiment, the body may comprise at least one layer of a first material which comprises a material suitable to carry an electrical charge. In another embodiment, the body may comprise a longitudinally extending bore formed within the blade.
The novel features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows.
Before explaining the various embodiments in detail, it should be noted that the embodiments are not limited in its application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative embodiments may be implemented or incorporated in other embodiments, variations and modifications, and may be practiced or carried out in various ways. For example, the surgical instruments and blade configurations disclosed below are illustrative only and not meant to limit the scope or application thereof. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments for the convenience of the reader and are not to limit the scope thereof.
The various embodiments relate, in general, to ultrasonic blades for use in surgical instruments and, more particularly, to ultrasonic blades comprising mist reducing features as described herein. The various embodiments relate, in general, to ultrasonic blades and instruments to improve visibility of the surgical site during surgery by reducing the mist plume created by fluid particles colliding with a distal end of an activated ultrasonic blade. Visibility of the surgical site may be improved through the mist reducing features of the ultrasonic blades which may comprise a tapered concave surface formed at the distal end of the blade, a tip coating, a lumen fluidically coupled to a spraying mechanism, a material to hold an electric charge, or any combination thereof. The term “tapered concave surface” is defined as a concave surface formed at a distal end of the blade that is tapered inwardly from its distal end to its proximal end in the direction indicated by arrow B, various embodiments of which are shown in
Examples of ultrasonic surgical instruments are disclosed in U.S. Pat. Nos. 5,322,055 and 5,954,736 and in combination with ultrasonic blades and surgical instruments disclosed in U.S. Pat. Nos. 6,309,400 B2, 6,278,218 B1, 6,283,981 B1, and 6,325,811 B1, for example, are incorporated herein by reference in their entirety. These references disclose ultrasonic surgical instruments and blade configurations where a longitudinal mode of the blade is excited. Because of asymmetry or asymmetries, ultrasonic blades also may exhibit transverse and/or torsional motion where the characteristic “wavelength” of this non-longitudinal motion is generally less than that of the general longitudinal motion of the blade and its extender portion. Therefore, the wave shape of the non-longitudinal motion will present nodal positions of transverse/torsional motion along the tissue effector while the net motion of the active blade along its tissue effector is non-zero (i.e., will have at least longitudinal motion along the length extending from its distal end, an antinode of longitudinal motion, to the first nodal position of longitudinal motion that is proximal to the tissue effector portion).
Certain embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those of ordinary skill in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting embodiments and that the scope of the various embodiments is defined solely by the claims. The features illustrated or described in connection with one embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the claims.
It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician gripping the hand piece assembly 60. Thus, the blade 50 is distal with respect to the more proximal hand piece assembly 60. It will be further appreciated that, for convenience and clarity, spatial terms such as “top” and “bottom” also are used herein with respect to the clinician gripping the hand piece assembly 60. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.
The distal end of the end-bell 20 is connected to the proximal end of the transduction portion 18, and the proximal end of the fore-bell 22 is connected to the distal end of the transduction portion 18. The fore-bell 22 and the end-bell 20 have a length determined by a number of variables, including the thickness of the transduction portion 18, the density and modulus of elasticity of the material used to manufacture the end-bell 20 and the fore-bell 22, and the resonant frequency of the ultrasonic transducer 14. The fore-bell 22 may be tapered inwardly from its proximal end to its distal end to amplify the ultrasonic vibration amplitude as the velocity transformer 28, or alternately may have no amplification. A suitable vibrational frequency range may be about 20 Hz to 120 kHz and a well-suited vibrational frequency range may be about 30-100 kHz. A suitable operational vibrational frequency may be approximately 55.5 kHz, for example.
Piezoelectric elements 32 may be fabricated from any suitable material, such as, for example, lead zirconate-titanate, lead meta-niobate, lead titanate, barium titanate, or other piezoelectric ceramic material. Each of positive electrodes 34, negative electrodes 36, and the piezoelectric elements 32 has a bore extending through the center. The positive and negative electrodes 34 and 36 are electrically coupled to wires 38 and 40, respectively. The wires 38 and 40 are encased within a cable 42 and electrically connectable to the ultrasonic signal generator 12 of the ultrasonic system 10.
The ultrasonic transducer 14 of the acoustic assembly 24 converts the electrical signal from the ultrasonic signal generator 12 into mechanical energy that results in primarily a standing acoustic wave of longitudinal vibratory motion of the ultrasonic transducer 14 and the end effector 50 at ultrasonic frequencies. In another embodiment, the vibratory motion of the ultrasonic transducer may act in a different direction. For example, the vibratory motion may comprise a local longitudinal component of a more complicated motion of the tip of the ultrasonic system 10. A suitable generator is available as model number GEN04, from Ethicon Endo-Surgery, Inc., Cincinnati, Ohio. When the acoustic assembly 24 is energized, a vibratory motion standing wave is generated through the acoustic assembly 24. The ultrasonic system 10 is designed to operate at a resonance such that an acoustic standing wave pattern of predetermined amplitude is produced. The amplitude of the vibratory motion at any point along the acoustic assembly 24 depends upon the location along the acoustic assembly 24 at which the vibratory motion is measured. A minimum or zero crossing in the vibratory motion standing wave is generally referred to as a node (i.e., where motion is minimal), and a local absolute value maximum or peak in the standing wave is generally referred to as an anti-node (i.e., where local motion is maximal). The distance between an anti-node and its nearest node is one-quarter wavelength (λ/4).
The wires 38 and 40 transmit an electrical signal from the ultrasonic signal generator 12 to the positive electrodes 34 and the negative electrodes 36. The piezoelectric elements 32 are energized by the electrical signal supplied from the ultrasonic signal generator 12 in response to an actuator 44, such as a foot switch, for example, to produce an acoustic standing wave in the acoustic assembly 24. The electrical signal causes disturbances in the piezoelectric elements 32 in the form of repeated small displacements resulting in large alternating compression and tension forces within the material. The repeated small displacements cause the piezoelectric elements 32 to expand and contract in a continuous manner along the axis of the voltage gradient, producing longitudinal waves of ultrasonic energy. The ultrasonic energy is transmitted through the acoustic assembly 24 to the single element end effector such as the blade 50 via a transmission component or an ultrasonic transmission waveguide 104.
In order for the acoustic assembly 24 to deliver energy to the single element end effector 50, all components of the acoustic assembly 24 must be acoustically coupled to the blade 50. The distal end of the ultrasonic transducer 14 may be acoustically coupled at the surface 30 to the proximal end of the ultrasonic transmission waveguide 104 by a threaded connection such as a stud 48.
The components of the acoustic assembly 24 are preferably acoustically tuned such that the length of any assembly is an integral number of one-half wavelengths (nλ/2), where the wavelength λ is the wavelength of a pre-selected or operating longitudinal vibration drive frequency fd of the acoustic assembly 24. It is also contemplated that the acoustic assembly 24 may incorporate any suitable arrangement of acoustic elements.
The blade 50 may have a length substantially equal to an integral multiple of one-half system wavelengths (nλ/2). A distal end 52 of the blade 50 may be disposed near an antinode in order to provide the maximum longitudinal excursion of the distal end. When the transducer assembly is energized, the distal end 52 of the blade 50 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 30 to 150 microns at a predetermined vibrational frequency of 55 kHz, for example.
The blade 50 may comprise features to reduce misting. For example, the blade 50 may comprise a tapered concave surface at the distal end 52, a coating formed at the distal end 52, a lumen fluidically coupled to a spraying mechanism, a material to hold an electric charge, or any combination thereof.
The blade 50 may be coupled to the ultrasonic transmission waveguide 104. The blade 50 and the ultrasonic transmission waveguide 104 as illustrated are formed as a single unit construction from a material suitable for transmission of ultrasonic energy. Examples of such materials include Ti6Al4V (an alloy of Titanium including Aluminum and Vanadium), Aluminum, Stainless Steel, or other suitable materials. Alternately, the blade 50 may be separable (and of differing composition) from the ultrasonic transmission waveguide 104, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The length of the ultrasonic transmission waveguide 104 may be substantially equal to an integral number of one-half wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 104 may be preferably fabricated from a solid core shaft constructed out of material suitable to propagate ultrasonic energy efficiently, such as the titanium alloy discussed above (i.e., Ti6Al4V) or any suitable aluminum alloy, or other alloys, for example.
The ultrasonic transmission waveguide 104 comprises a longitudinally projecting attachment post 54 at a proximal end to couple to the surface 30 of the ultrasonic transmission waveguide 104 by a threaded connection such as the stud 48. In the embodiment illustrated in
As shown in
The hub 62 of the sheath 58 is preferably constructed from plastic and the tubular member 64 is fabricated from stainless steel. Alternatively, the ultrasonic transmission waveguide 104 may comprise polymeric material surrounding it to isolate it from outside contact.
The distal end of the ultrasonic transmission waveguide 104 may be coupled to the proximal end of the blade 50 by an internal threaded connection, preferably at or near an antinode. It is contemplated that the blade 50 may be attached to the ultrasonic transmission waveguide 104 by any suitable means, such as a welded joint or the like. Although the blade 50 may be detachable from the ultrasonic transmission waveguide 104, it is also contemplated that the single element end effector (e.g., the blade 50) and the ultrasonic transmission waveguide 104 may be formed as a single unitary piece.
As previously discussed with reference to the ultrasonic system 10 shown in
In the embodiment illustrated in
The length of the blade 50 may be substantially equal to an integral multiple of one-half system wavelengths (nλ/2). The distal end 52 of the blade 50 may be disposed near an anti-node in order to provide the maximum longitudinal excursion of the distal end 52. When the transducer assembly is energized, the distal end 52 of the blade 50 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 30 to 150 microns at a predetermined vibrational frequency.
The blade 50 may be coupled to the ultrasonic transmission waveguide 104. The blade 50 and the ultrasonic transmission guide 104 as illustrated are formed as a single unit of construction from a material suitable for transmission of ultrasonic energy such as, for example, Ti6Al4V (an alloy of titanium including aluminum and vanadium), aluminum, stainless steel, other known materials, or combinations thereof. Alternately, the blade 50 may be separable (and of differing composition) from the ultrasonic transmission waveguide 104, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The length of the ultrasonic transmission waveguide 104 may be substantially equal to an integral number of one-half system wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 104 also may be preferably fabricated from a solid core shaft constructed out of material that propagates ultrasonic energy efficiently, such as titanium alloy (e.g., Ti6Al4V) or an aluminum alloy, for example. The ultrasonic transmission waveguide 104 also may be fabricated from a hollow core shaft constructed out of similar materials. The ultrasonic transmission waveguide 104 also may be fabricated with a combination solid/hollow core shaft, for example, a solid core shaft with hollow cavities positioned at various locations along the length of the shaft.
In the embodiment illustrated in
The clamped coagulating shears 1002 preferably includes an instrument housing 1004 and an elongated member 1006. The elongated member 1006 may be selectively rotated with respect to the instrument housing 1004. The instrument housing 1004 includes a pivoting handle portion 1028 and a fixed handle portion 1029.
An indexing mechanism (not shown) is disposed within a cavity of the instrument housing 1004. The indexing mechanism is preferably coupled or attached on an inner tube 1014 to translate movement of the pivoting handle portion 1028 to linear motion of the inner tube 1014 to open and close the multi-element end assembly 1008. When the pivoting handle portion 1028 is moved toward the fixed handle portion 1029, the indexing mechanism slide the inner tube 1014 rearward to pivot the multi-element end assembly 1008 into a closed position. The movement of the pivoting handle portion 1028 in the opposite direction slides the indexing mechanism to displace the inner tube 1014 in the opposite direction, i.e., forwardly, and hence pivot the multi-element end assembly 1008 into its open position in the direction indicated by arrow 1020 as shown in
The pivoting handle portion 1028 includes a thumb loop 1030. A pivot pin 1032 is disposed through a first hole of the pivoting handle portion 1028 to allow pivoting as shown by arrow 1034 in
The elongated member 1006 of the clamped coagulating shears 1002 extends from the instrument housing 1004. The elongated member 1006 preferably includes an outer member or outer tube 1012, an inner member or inner tube 1014, and a transmission component or ultrasonic transmission waveguide 104.
The multi-element end effector or multi-element end assembly 1008 includes a clamp arm assembly 1018, a tissue pad 1036, and an ultrasonic blade 1016. The clamp arm assembly 1018 is pivotally mounted about a pivot pin (not shown) to rotate in the direction indicated by arrow 1038. The ultrasonic blade 1016 comprises a tapered concave surface 1040 extending inwardly into the blade body.
The ultrasonic surgical instrument 100 and the clamped coagulating shears 1002 may be sterilized by methods known in the art such as, for example, gamma radiation sterilization, Ethelyne Oxide processes, autoclaving, soaking in sterilization liquid, or other known processes. In the embodiment illustrated in
In the embodiment illustrated in
In various embodiments, the tapered concave surface 121 may extend inwardly into the blade body 122 from a first edge 124 which may be located at the distal end 134 of the blade body 122. As previously discussed, the surface 121 may be substantially concave and may be tapered inwardly into the blade body 122. In one embodiment, as illustrated in
The tapered concave surface 121 may be configured to produce a substantially convergent jet 135 of fluid mist, as shown in
With reference now back to
In various other embodiments, the tapered concave surface 221 of the blade body 122 may define various other symmetrical or asymmetrical shapes. In one embodiment, as shown in
In another embodiment, as shown in
In at least one embodiment, the blade may comprise a variety of shapes. For example, the blade may be curved. The blade may be curved in any direction. In addition, the blade may comprise various cross-sections. For example, the blade may comprise a square cross-section. All of these blade shapes may comprise an axis defined between the proximal end 132 and the distal end 134 of the blade.
As previously discussed, in various embodiments, the tapered concave surface may extend inwardly into the blade body 122 in direction B from a first edge 124 either symmetrically or asymmetrically. This extension may occur at or near the longitudinal central axis 127 of the blade body 122. For example, with respect to the embodiment illustrated in
In various embodiments, as shown in
The gobulization of the fluid may be caused by differences between the surface tension of the material 150 and the surface tension of the fluid in contact with the material 150. The material 150 may have a surface tension which is less than the surface tension of the fluid which may cause the fluid to globulize on the surface of the material 150. A fluid may form globules or “beads” on surfaces coated with a material where the surface tension of the material 150 on the surface 156 is less than the surface tension of the fluid. The formation of globules may prevent the “wetting” or formation of a layer of fluid spreading over the surface of the coated portion 129 of the blade body 122. The globules 152 may be pushed off of the blade body 122 through the vibrating motion of the end effector 50 unlike a layer of fluid which may have to be atomized from the surface thus causing a mist to form. The effects of the differences between the surface tension of the material 150 and the surface tension of the fluid may be illustrated in terms of a contact angle formed between a fluid interface and a surface.
In various embodiments, the surface 158 of the material 150 may be hydrophobic or superhydrophobic. The first material 150 may comprise any one of polytetrafluoroethylene (TEFLON®), polypropylene, polyethylene, waxes, polycaprolactone, any combination thereof, or any other suitable hydrophobic or superhydrophobic material. For example, the first material 150 may comprise at least one of a polypropylene wax hydrocarbon mixture or TEFLON®. The first material 150 may be applied to the surface through a variety of coating techniques including dipping, spraying, brushing, drying, melting, sintering, fused curing, and any other suitable method for applying hydrophobic materials. Other methods for applying hydrophobic materials may include material deposition techniques that are well known in the art. More details regarding hydrophobic and superhydrophobic materials and methods for applying those materials to a surface are described by U.S. Pat. No. 7,041,088 and U.S. Pat. No. 6,663,941, which are incorporated herein by reference.
In various other embodiments, as shown in
At least a second portion of the blade body 122 comprises at least one layer of a second material 162. The second material 162 may comprise an electrically insulative material. The second material 162 may be located between the first material 160 and the blade body 122. The second material 162 may insulate the blade 520, and the blade body 122, from electrical charges. The second material 162 may be an electret material which may be made from silicon dioxide, fluoropolymer, polypropylene or any other suitable material. These materials may hold a constant or slow decaying charge. The first material 160 may be a metallic layer or a vapor deposited layer acting as a floating conductor wherein wires may not be required to convey a charge to the second material 162 from an electrical source.
In another embodiment, the electric charge carried by the first material 160 may be the opposite polarity as the nominal electric charge carried by the fluid. The opposite electric charges may cause the portion 129 of the blade body 122 covered with the first material to attract the fluid. For example, if the first material 160 has a negative charge and the fluid has a positive charge, the fluid will be attracted by the first material 160. Accordingly, the first material 160 acts as a hydrophilic surface. Accordingly, electric charge on the coating materials may be selected such that they exhibit opposite charges to that of the fluid to create attraction rather than repulsion between the blade body 122 and the fluid. This may enable surgical “smoke” or mist to globulize as it collects on the surface of the blade body 122. In addition, this technique may be employed to attract other materials or constituents, such as, drug molecules, fibrin, and natural adhesives to the treatment site. These other materials or constituents may be introduced in a liquid suspension. The difference in charges between the blade body 12 ad the fluid would act to concentrate these other materials or constituents in the vicinity of the distal end of the blade body 122.
In various embodiments, as shown in
The ultrasonic blade 120 comprises a treatment region 128 that is suitable to effect tissue, such as, for example, cut, coagulate, reshape, scrape, and remove tissue. A distal end 134 of the treatment region 128 may also comprise a tip with a cutting edge. Additional cutting edges may be positioned laterally along both sides of the treatment region 128. In one embodiment, the cutting edges extend from the proximal end 132 to the distal end 134 of the treatment region 128.
The ultrasonic blades as discussed herein may be fabricated from a material suitable for transmission of ultrasonic energy such as, for example, Ti6Al4V, Aluminum, Stainless Steel, or other known materials. The ultrasonic blade may be used in a single-element end effector (e.g., a scalpel, hook, or ball coagulator) as discussed with reference to ultrasonic system 10 and
The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
Preferably, the various embodiments described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.
It is preferred that the device is sterilized. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam.
Although various embodiments have been described herein, many modifications and variations to those embodiments may be implemented. For example, different types of end effectors may be employed. In addition, combinations of the described embodiments may be used. For example, a concave blade tip may be coated with a hydrophobic material. Also, where materials are disclosed for certain components, other materials may be used. The foregoing description and following claims are intended to cover all such modification and variations.
Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Number | Name | Date | Kind |
---|---|---|---|
2704333 | Calosi et al. | Mar 1955 | A |
2736960 | Armstrong | Mar 1956 | A |
2849788 | Creek | Sep 1958 | A |
RE25033 | Balamuth et al. | Aug 1961 | E |
3015961 | Roney | Jan 1962 | A |
3513848 | Winston et al. | May 1970 | A |
3526219 | Balamuth | Sep 1970 | A |
3614484 | Shoh | Oct 1971 | A |
3636943 | Balamuth | Jan 1972 | A |
3776238 | Peyman et al. | Dec 1973 | A |
3805787 | Banko | Apr 1974 | A |
3830098 | Antonevich | Aug 1974 | A |
3854737 | Gilliam, Sr. | Dec 1974 | A |
3862630 | Balamuth | Jan 1975 | A |
3900823 | Sokal et al. | Aug 1975 | A |
3918442 | Nikolaev et al. | Nov 1975 | A |
3946738 | Newton et al. | Mar 1976 | A |
3955859 | Stella et al. | May 1976 | A |
3956826 | Perdreaux, Jr. | May 1976 | A |
4156187 | Murry et al. | May 1979 | A |
4188927 | Harris | Feb 1980 | A |
4200106 | Douvas et al. | Apr 1980 | A |
4306570 | Matthews | Dec 1981 | A |
4445063 | Smith | Apr 1984 | A |
4491132 | Aikins | Jan 1985 | A |
4574615 | Bower et al. | Mar 1986 | A |
4617927 | Manes | Oct 1986 | A |
4633119 | Thompson | Dec 1986 | A |
4634420 | Spinosa et al. | Jan 1987 | A |
4640279 | Beard | Feb 1987 | A |
4649919 | Thimsen et al. | Mar 1987 | A |
4708127 | Abdelghani | Nov 1987 | A |
4712722 | Hood et al. | Dec 1987 | A |
4827911 | Broadwin et al. | May 1989 | A |
4832683 | Idemoto et al. | May 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4865159 | Jamison | Sep 1989 | A |
4896009 | Pawlowski | Jan 1990 | A |
4903696 | Stasz et al. | Feb 1990 | A |
4922902 | Wuchinich et al. | May 1990 | A |
4965532 | Sakurai | Oct 1990 | A |
4979952 | Kubota et al. | Dec 1990 | A |
4981756 | Rhandhawa | Jan 1991 | A |
5026387 | Thomas | Jun 1991 | A |
5112300 | Ureche | May 1992 | A |
5123903 | Quaid et al. | Jun 1992 | A |
5126618 | Takahashi et al. | Jun 1992 | A |
5162044 | Gahn et al. | Nov 1992 | A |
5167725 | Clark et al. | Dec 1992 | A |
D332660 | Rawson et al. | Jan 1993 | S |
5176695 | Dulebohn | Jan 1993 | A |
5184605 | Grzeszykowski | Feb 1993 | A |
5213569 | Davis | May 1993 | A |
5221282 | Wuchinich | Jun 1993 | A |
5226909 | Evans et al. | Jul 1993 | A |
5226910 | Kajiyama et al. | Jul 1993 | A |
5241236 | Sasaki et al. | Aug 1993 | A |
5257988 | L'Esperance, Jr. | Nov 1993 | A |
5261922 | Hood | Nov 1993 | A |
5263957 | Davison | Nov 1993 | A |
5275609 | Pingleton et al. | Jan 1994 | A |
5282800 | Foshee et al. | Feb 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
D347474 | Olson | May 1994 | S |
5322055 | Davison et al. | Jun 1994 | A |
5324299 | Davison et al. | Jun 1994 | A |
5344420 | Hilal et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5357423 | Weaver et al. | Oct 1994 | A |
5366466 | Christian et al. | Nov 1994 | A |
D354564 | Medema | Jan 1995 | S |
5381067 | Greenstein et al. | Jan 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5411481 | Allen et al. | May 1995 | A |
5419761 | Narayanan et al. | May 1995 | A |
5421829 | Olichney et al. | Jun 1995 | A |
5438997 | Sieben et al. | Aug 1995 | A |
5449370 | Vaitekunas | Sep 1995 | A |
5471988 | Fujio et al. | Dec 1995 | A |
5483501 | Park et al. | Jan 1996 | A |
5486162 | Brumbach | Jan 1996 | A |
5500216 | Julian et al. | Mar 1996 | A |
5501654 | Failla et al. | Mar 1996 | A |
5505693 | Mackool | Apr 1996 | A |
5527331 | Kresch et al. | Jun 1996 | A |
5562609 | Brumbach | Oct 1996 | A |
5562610 | Brumbach | Oct 1996 | A |
5601601 | Tal et al. | Feb 1997 | A |
5603773 | Campbell | Feb 1997 | A |
5607436 | Pratt et al. | Mar 1997 | A |
5618492 | Auten et al. | Apr 1997 | A |
5628760 | Knoepfler | May 1997 | A |
5630420 | Vaitekunas | May 1997 | A |
D381077 | Hunt | Jul 1997 | S |
5651780 | Jackson et al. | Jul 1997 | A |
5653713 | Michelson | Aug 1997 | A |
5669922 | Hood | Sep 1997 | A |
5674235 | Parisi | Oct 1997 | A |
5690269 | Bolanos et al. | Nov 1997 | A |
5694936 | Fujimoto et al. | Dec 1997 | A |
5713896 | Nardella | Feb 1998 | A |
5730752 | Alden et al. | Mar 1998 | A |
5733074 | Stöck et al. | Mar 1998 | A |
5741226 | Strukel et al. | Apr 1998 | A |
5792135 | Madhani et al. | Aug 1998 | A |
5810859 | DiMatteo et al. | Sep 1998 | A |
5817084 | Jensen | Oct 1998 | A |
5827323 | Klieman et al. | Oct 1998 | A |
5828160 | Sugishita | Oct 1998 | A |
5836897 | Sakurai et al. | Nov 1998 | A |
5843109 | Mehta et al. | Dec 1998 | A |
5878193 | Wang et al. | Mar 1999 | A |
5879364 | Bromfield et al. | Mar 1999 | A |
5893835 | Witt et al. | Apr 1999 | A |
5897569 | Kellogg et al. | Apr 1999 | A |
5906628 | Miyawaki et al. | May 1999 | A |
5935143 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5938633 | Beaupre | Aug 1999 | A |
5944718 | Austin et al. | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5954736 | Bishop et al. | Sep 1999 | A |
5954746 | Holthaus et al. | Sep 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957943 | Vaitekunas | Sep 1999 | A |
5968007 | Simon et al. | Oct 1999 | A |
5968060 | Kellogg | Oct 1999 | A |
D416089 | Barton et al. | Nov 1999 | S |
5980510 | Tsonton et al. | Nov 1999 | A |
5989274 | Davison et al. | Nov 1999 | A |
5989275 | Estabrook et al. | Nov 1999 | A |
5993972 | Reich et al. | Nov 1999 | A |
6024741 | Williamson, IV et al. | Feb 2000 | A |
6033375 | Brumbach | Mar 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6056735 | Okada et al. | May 2000 | A |
6063098 | Houser et al. | May 2000 | A |
6066132 | Chen et al. | May 2000 | A |
6068647 | Witt et al. | May 2000 | A |
6077285 | Boukhny | Jun 2000 | A |
6083191 | Rose | Jul 2000 | A |
6086584 | Miller | Jul 2000 | A |
6090120 | Wright et al. | Jul 2000 | A |
6109500 | Alli et al. | Aug 2000 | A |
6110127 | Suzuki | Aug 2000 | A |
6113594 | Savage | Sep 2000 | A |
6129735 | Okada et al. | Oct 2000 | A |
6132368 | Cooper | Oct 2000 | A |
6139320 | Hahn | Oct 2000 | A |
6139561 | Shibata et al. | Oct 2000 | A |
6142615 | Qiu et al. | Nov 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6159175 | Strukel et al. | Dec 2000 | A |
6204592 | Hur | Mar 2001 | B1 |
6206844 | Reichel et al. | Mar 2001 | B1 |
6210403 | Klicek | Apr 2001 | B1 |
6214023 | Whipple et al. | Apr 2001 | B1 |
6231565 | Tovey et al. | May 2001 | B1 |
6233476 | Strommer et al. | May 2001 | B1 |
6238366 | Savage et al. | May 2001 | B1 |
6252110 | Uemura et al. | Jun 2001 | B1 |
D444365 | Bass et al. | Jul 2001 | S |
6254623 | Haibel, Jr. et al. | Jul 2001 | B1 |
6258034 | Hanafy | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6270831 | Kumar et al. | Aug 2001 | B2 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6274963 | Estabrook et al. | Aug 2001 | B1 |
6277115 | Saadat | Aug 2001 | B1 |
6278218 | Madan et al. | Aug 2001 | B1 |
6283981 | Beaupre | Sep 2001 | B1 |
6309400 | Beaupre | Oct 2001 | B2 |
6319221 | Savage et al. | Nov 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6328751 | Beaupre | Dec 2001 | B1 |
6340352 | Okada et al. | Jan 2002 | B1 |
6352532 | Kramer et al. | Mar 2002 | B1 |
6364888 | Niemeyer et al. | Apr 2002 | B1 |
6379320 | Lafon et al. | Apr 2002 | B1 |
D457958 | Dycus et al. | May 2002 | S |
6383194 | Pothula | May 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6388657 | Natoli | May 2002 | B1 |
6391042 | Cimino | May 2002 | B1 |
6405733 | Fogarty et al. | Jun 2002 | B1 |
6416486 | Wampler | Jul 2002 | B1 |
6423073 | Bowman | Jul 2002 | B2 |
6423082 | Houser et al. | Jul 2002 | B1 |
6428539 | Baxter et al. | Aug 2002 | B1 |
6432118 | Messerly | Aug 2002 | B1 |
6436114 | Novak et al. | Aug 2002 | B1 |
6436115 | Beaupre | Aug 2002 | B1 |
6443969 | Novak et al. | Sep 2002 | B1 |
6454781 | Witt et al. | Sep 2002 | B1 |
6454782 | Schwemberger | Sep 2002 | B1 |
6458142 | Faller et al. | Oct 2002 | B1 |
6480796 | Wiener | Nov 2002 | B2 |
6485490 | Wampler et al. | Nov 2002 | B2 |
6491708 | Madan et al. | Dec 2002 | B2 |
6497715 | Satou | Dec 2002 | B2 |
6500176 | Truckai et al. | Dec 2002 | B1 |
6500188 | Harper et al. | Dec 2002 | B2 |
6524316 | Nicholson et al. | Feb 2003 | B1 |
6527736 | Attinger et al. | Mar 2003 | B1 |
6533784 | Truckai et al. | Mar 2003 | B2 |
6537291 | Friedman et al. | Mar 2003 | B2 |
6543452 | Lavigne | Apr 2003 | B1 |
6543456 | Freeman | Apr 2003 | B1 |
6544260 | Markel et al. | Apr 2003 | B1 |
6561983 | Cronin et al. | May 2003 | B2 |
6572632 | Zisterer et al. | Jun 2003 | B2 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6589200 | Schwemberger et al. | Jul 2003 | B1 |
6589239 | Khandkar et al. | Jul 2003 | B2 |
6616450 | Mossle et al. | Sep 2003 | B2 |
6623501 | Heller et al. | Sep 2003 | B2 |
6626926 | Friedman et al. | Sep 2003 | B2 |
6633234 | Wiener et al. | Oct 2003 | B2 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6662127 | Wiener et al. | Dec 2003 | B2 |
6663941 | Brown et al. | Dec 2003 | B2 |
6669690 | Okada et al. | Dec 2003 | B1 |
6676660 | Wampler et al. | Jan 2004 | B2 |
6678621 | Wiener et al. | Jan 2004 | B2 |
6679899 | Wiener et al. | Jan 2004 | B2 |
6682544 | Mastri et al. | Jan 2004 | B2 |
6689146 | Himes | Feb 2004 | B1 |
6716215 | David et al. | Apr 2004 | B1 |
6731047 | Kauf et al. | May 2004 | B2 |
6733506 | McDevitt et al. | May 2004 | B1 |
6762535 | Take et al. | Jul 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773443 | Truwit et al. | Aug 2004 | B2 |
6773444 | Messerly | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6786382 | Hoffman | Sep 2004 | B1 |
6786383 | Stegelmann | Sep 2004 | B2 |
6790216 | Ishikawa | Sep 2004 | B1 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6828712 | Battaglin et al. | Dec 2004 | B2 |
6869439 | White et al. | Mar 2005 | B2 |
6875220 | Du et al. | Apr 2005 | B2 |
6905497 | Truckai et al. | Jun 2005 | B2 |
6908472 | Wiener et al. | Jun 2005 | B2 |
6913579 | Truckai et al. | Jul 2005 | B2 |
6926716 | Baker et al. | Aug 2005 | B2 |
6929632 | Nita et al. | Aug 2005 | B2 |
6929644 | Truckai et al. | Aug 2005 | B2 |
D509589 | Wells | Sep 2005 | S |
6942677 | Nita et al. | Sep 2005 | B2 |
6945981 | Donofrio et al. | Sep 2005 | B2 |
D511145 | Donofrio et al. | Nov 2005 | S |
6976844 | Hickok et al. | Dec 2005 | B2 |
6976969 | Messerly | Dec 2005 | B2 |
6977495 | Donofrio | Dec 2005 | B2 |
6984220 | Wuchinich | Jan 2006 | B2 |
7011657 | Truckai et al. | Mar 2006 | B2 |
7033357 | Baxter et al. | Apr 2006 | B2 |
7041083 | Chu et al. | May 2006 | B2 |
7041088 | Nawrocki et al. | May 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7070597 | Truckai et al. | Jul 2006 | B2 |
7074219 | Levine et al. | Jul 2006 | B2 |
7077039 | Gass et al. | Jul 2006 | B2 |
7077853 | Kramer et al. | Jul 2006 | B2 |
7083619 | Truckai et al. | Aug 2006 | B2 |
7087054 | Truckai et al. | Aug 2006 | B2 |
7101378 | Salameh et al. | Sep 2006 | B2 |
7108695 | Witt et al. | Sep 2006 | B2 |
7112201 | Truckai et al. | Sep 2006 | B2 |
7118564 | Ritchie et al. | Oct 2006 | B2 |
7124932 | Isaacson et al. | Oct 2006 | B2 |
7125409 | Truckai et al. | Oct 2006 | B2 |
7135018 | Ryan et al. | Nov 2006 | B2 |
7135030 | Schwemberger et al. | Nov 2006 | B2 |
7153315 | Miller | Dec 2006 | B2 |
D536093 | Nakajima et al. | Jan 2007 | S |
7156189 | Bar-Cohen et al. | Jan 2007 | B1 |
7156853 | Muratsu | Jan 2007 | B2 |
7157058 | Marhasin et al. | Jan 2007 | B2 |
7159750 | Racenet et al. | Jan 2007 | B2 |
7163548 | Stulen et al. | Jan 2007 | B2 |
7169146 | Truckai et al. | Jan 2007 | B2 |
7179271 | Friedman et al. | Feb 2007 | B2 |
7186253 | Truckai et al. | Mar 2007 | B2 |
7189233 | Truckai et al. | Mar 2007 | B2 |
7204820 | Akahoshi | Apr 2007 | B2 |
7220951 | Truckai et al. | May 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7229455 | Sakurai et al. | Jun 2007 | B2 |
7273483 | Wiener et al. | Sep 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7311709 | Truckai et al. | Dec 2007 | B2 |
7317955 | McGreevy | Jan 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7331410 | Yong et al. | Feb 2008 | B2 |
7353068 | Tanaka et al. | Apr 2008 | B2 |
7354440 | Truckal et al. | Apr 2008 | B2 |
7380695 | Doll et al. | Jun 2008 | B2 |
7380696 | Shelton, IV et al. | Jun 2008 | B2 |
7381209 | Truckai et al. | Jun 2008 | B2 |
7390317 | Taylor et al. | Jun 2008 | B2 |
7404508 | Smith et al. | Jul 2008 | B2 |
7408288 | Hara | Aug 2008 | B2 |
D576725 | Shumer et al. | Sep 2008 | S |
D578643 | Shumer et al. | Oct 2008 | S |
D578644 | Shumer et al. | Oct 2008 | S |
D578645 | Shumer et al. | Oct 2008 | S |
7431704 | Babaev | Oct 2008 | B2 |
7441684 | Shelton, IV et al. | Oct 2008 | B2 |
7455208 | Wales et al. | Nov 2008 | B2 |
7472815 | Shelton, IV et al. | Jan 2009 | B2 |
7479148 | Beaupre | Jan 2009 | B2 |
7479160 | Branch et al. | Jan 2009 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7503893 | Kucklick | Mar 2009 | B2 |
7506790 | Shelton, IV | Mar 2009 | B2 |
7506791 | Omaits et al. | Mar 2009 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7534243 | Chin et al. | May 2009 | B1 |
D594983 | Price et al. | Jun 2009 | S |
7549564 | Boudreaux | Jun 2009 | B2 |
7559450 | Wales et al. | Jul 2009 | B2 |
7567012 | Namikawa | Jul 2009 | B2 |
7654431 | Hueil et al. | Feb 2010 | B2 |
7665647 | Shelton, IV et al. | Feb 2010 | B2 |
7670334 | Hueil et al. | Mar 2010 | B2 |
7674263 | Ryan | Mar 2010 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7713202 | Boukhny et al. | May 2010 | B2 |
7714481 | Sakai | May 2010 | B2 |
D618797 | Price et al. | Jun 2010 | S |
7751115 | Song | Jul 2010 | B2 |
7770774 | Mastri et al. | Aug 2010 | B2 |
7770775 | Shelton, IV et al. | Aug 2010 | B2 |
7780054 | Wales | Aug 2010 | B2 |
7780659 | Okada et al. | Aug 2010 | B2 |
7784662 | Wales et al. | Aug 2010 | B2 |
7798386 | Schall et al. | Sep 2010 | B2 |
7806891 | Nowlin et al. | Oct 2010 | B2 |
7810693 | Broehl et al. | Oct 2010 | B2 |
7824401 | Manzo et al. | Nov 2010 | B2 |
7854735 | Houser et al. | Dec 2010 | B2 |
D631155 | Peine et al. | Jan 2011 | S |
7861906 | Doll et al. | Jan 2011 | B2 |
7876030 | Taki et al. | Jan 2011 | B2 |
D631965 | Price et al. | Feb 2011 | S |
7905881 | Masuda et al. | Mar 2011 | B2 |
7959050 | Smith et al. | Jun 2011 | B2 |
7959626 | Hong et al. | Jun 2011 | B2 |
8038693 | Allen | Oct 2011 | B2 |
8061014 | Smith et al. | Nov 2011 | B2 |
8089197 | Rinner et al. | Jan 2012 | B2 |
8157145 | Shelton, IV et al. | Apr 2012 | B2 |
8177800 | Spitz et al. | May 2012 | B2 |
D661801 | Price et al. | Jun 2012 | S |
D661802 | Price et al. | Jun 2012 | S |
D661803 | Price et al. | Jun 2012 | S |
D661804 | Price et al. | Jun 2012 | S |
8253303 | Giordano et al. | Aug 2012 | B2 |
20010025184 | Messerly | Sep 2001 | A1 |
20010031950 | Ryan | Oct 2001 | A1 |
20010039419 | Francischelli et al. | Nov 2001 | A1 |
20020002377 | Cimino | Jan 2002 | A1 |
20020019649 | Sikora et al. | Feb 2002 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020077550 | Rabiner et al. | Jun 2002 | A1 |
20020156493 | Houser et al. | Oct 2002 | A1 |
20030055443 | Spotnitz | Mar 2003 | A1 |
20030204199 | Novak et al. | Oct 2003 | A1 |
20030212332 | Fenton et al. | Nov 2003 | A1 |
20030212422 | Fenton et al. | Nov 2003 | A1 |
20040030254 | Babaev | Feb 2004 | A1 |
20040047485 | Sherrit et al. | Mar 2004 | A1 |
20040054364 | Aranyi et al. | Mar 2004 | A1 |
20040092921 | Kadziauskas et al. | May 2004 | A1 |
20040097919 | Wellman et al. | May 2004 | A1 |
20040097996 | Rabiner et al. | May 2004 | A1 |
20040199193 | Hayashi et al. | Oct 2004 | A1 |
20040204728 | Haefner | Oct 2004 | A1 |
20040243157 | Connor et al. | Dec 2004 | A1 |
20040260300 | Gorensek et al. | Dec 2004 | A1 |
20050033337 | Muir et al. | Feb 2005 | A1 |
20050049546 | Messerly et al. | Mar 2005 | A1 |
20050143769 | White et al. | Jun 2005 | A1 |
20050149108 | Cox | Jul 2005 | A1 |
20050165345 | Laufer et al. | Jul 2005 | A1 |
20050177184 | Easley | Aug 2005 | A1 |
20050192610 | Houser et al. | Sep 2005 | A1 |
20050209620 | Du et al. | Sep 2005 | A1 |
20050261581 | Hughes et al. | Nov 2005 | A1 |
20050261588 | Makin et al. | Nov 2005 | A1 |
20050288659 | Kimura et al. | Dec 2005 | A1 |
20060019114 | Thies et al. | Jan 2006 | A1 |
20060030797 | Zhou et al. | Feb 2006 | A1 |
20060063130 | Hayman et al. | Mar 2006 | A1 |
20060079878 | Houser | Apr 2006 | A1 |
20060084963 | Messerly | Apr 2006 | A1 |
20060116675 | McClurken et al. | Jun 2006 | A1 |
20060190034 | Nishizawa et al. | Aug 2006 | A1 |
20060211943 | Beaupre | Sep 2006 | A1 |
20060235306 | Cotter et al. | Oct 2006 | A1 |
20060253050 | Yoshimine et al. | Nov 2006 | A1 |
20070016235 | Tanaka et al. | Jan 2007 | A1 |
20070016236 | Beaupre | Jan 2007 | A1 |
20070038157 | Yamada et al. | Feb 2007 | A1 |
20070055228 | Berg et al. | Mar 2007 | A1 |
20070060915 | Kucklick | Mar 2007 | A1 |
20070060935 | Schwardt et al. | Mar 2007 | A1 |
20070063618 | Bromfield | Mar 2007 | A1 |
20070106317 | Shelton, IV et al. | May 2007 | A1 |
20070129716 | Daw et al. | Jun 2007 | A1 |
20070130771 | Ehlert et al. | Jun 2007 | A1 |
20070131034 | Ehlert et al. | Jun 2007 | A1 |
20070149881 | Rabin | Jun 2007 | A1 |
20070162050 | Sartor | Jul 2007 | A1 |
20070173872 | Neuenfeldt | Jul 2007 | A1 |
20070185380 | Kucklick | Aug 2007 | A1 |
20070219481 | Babaev | Sep 2007 | A1 |
20070239028 | Houser et al. | Oct 2007 | A1 |
20070249941 | Salehi et al. | Oct 2007 | A1 |
20070260234 | McCullagh et al. | Nov 2007 | A1 |
20070265560 | Soltani et al. | Nov 2007 | A1 |
20070275348 | Lemon | Nov 2007 | A1 |
20070282335 | Young et al. | Dec 2007 | A1 |
20070287933 | Phan et al. | Dec 2007 | A1 |
20080009848 | Paraschiv et al. | Jan 2008 | A1 |
20080058585 | Novak et al. | Mar 2008 | A1 |
20080058775 | Darian et al. | Mar 2008 | A1 |
20080058845 | Shimizu et al. | Mar 2008 | A1 |
20080082039 | Babaev | Apr 2008 | A1 |
20080082098 | Tanaka et al. | Apr 2008 | A1 |
20080172051 | Masuda et al. | Jul 2008 | A1 |
20080177268 | Daum et al. | Jul 2008 | A1 |
20080188878 | Young | Aug 2008 | A1 |
20080200940 | Eichmann et al. | Aug 2008 | A1 |
20080208231 | Ota et al. | Aug 2008 | A1 |
20080234708 | Houser et al. | Sep 2008 | A1 |
20080234709 | Houser | Sep 2008 | A1 |
20080234710 | Neurohr et al. | Sep 2008 | A1 |
20080234711 | Houser et al. | Sep 2008 | A1 |
20080243106 | Coe et al. | Oct 2008 | A1 |
20080245371 | Gruber | Oct 2008 | A1 |
20080249553 | Gruber et al. | Oct 2008 | A1 |
20080262490 | Williams | Oct 2008 | A1 |
20080281200 | Voic et al. | Nov 2008 | A1 |
20080287948 | Newton et al. | Nov 2008 | A1 |
20090030311 | Stulen et al. | Jan 2009 | A1 |
20090030351 | Wiener et al. | Jan 2009 | A1 |
20090030437 | Houser et al. | Jan 2009 | A1 |
20090030438 | Stulen | Jan 2009 | A1 |
20090036911 | Stulen | Feb 2009 | A1 |
20090036912 | Wiener et al. | Feb 2009 | A1 |
20090036913 | Wiener et al. | Feb 2009 | A1 |
20090036914 | Houser | Feb 2009 | A1 |
20090054886 | Yachi et al. | Feb 2009 | A1 |
20090054894 | Yachi | Feb 2009 | A1 |
20090076506 | Baker | Mar 2009 | A1 |
20090082716 | Akahoshi | Mar 2009 | A1 |
20090105750 | Price et al. | Apr 2009 | A1 |
20090118802 | Mioduski et al. | May 2009 | A1 |
20090138006 | Bales et al. | May 2009 | A1 |
20090143795 | Robertson | Jun 2009 | A1 |
20090143796 | Stulen et al. | Jun 2009 | A1 |
20090143797 | Smith et al. | Jun 2009 | A1 |
20090143798 | Smith et al. | Jun 2009 | A1 |
20090143799 | Smith et al. | Jun 2009 | A1 |
20090143800 | Deville et al. | Jun 2009 | A1 |
20090143801 | Deville et al. | Jun 2009 | A1 |
20090143802 | Deville et al. | Jun 2009 | A1 |
20090143803 | Palmer et al. | Jun 2009 | A1 |
20090143804 | Palmer et al. | Jun 2009 | A1 |
20090143805 | Palmer et al. | Jun 2009 | A1 |
20090143806 | Witt et al. | Jun 2009 | A1 |
20090270853 | Yachi et al. | Oct 2009 | A1 |
20090318945 | Yoshimine et al. | Dec 2009 | A1 |
20090327715 | Smith et al. | Dec 2009 | A1 |
20100004668 | Smith et al. | Jan 2010 | A1 |
20100004669 | Smith et al. | Jan 2010 | A1 |
20100016785 | Takuma | Jan 2010 | A1 |
20100030248 | Palmer et al. | Feb 2010 | A1 |
20100036370 | Mirel et al. | Feb 2010 | A1 |
20100036405 | Giordano et al. | Feb 2010 | A1 |
20100069940 | Miller et al. | Mar 2010 | A1 |
20100158307 | Kubota et al. | Jun 2010 | A1 |
20100179577 | Houser | Jul 2010 | A1 |
20100187283 | Crainich et al. | Jul 2010 | A1 |
20100193567 | Scheib et al. | Aug 2010 | A1 |
20100298743 | Nield et al. | Nov 2010 | A1 |
20100298851 | Nield | Nov 2010 | A1 |
20100331869 | Voegele et al. | Dec 2010 | A1 |
20100331870 | Wan et al. | Dec 2010 | A1 |
20100331871 | Nield et al. | Dec 2010 | A1 |
20100331872 | Houser et al. | Dec 2010 | A1 |
20110009850 | Main et al. | Jan 2011 | A1 |
20110015627 | DiNardo et al. | Jan 2011 | A1 |
20110015631 | Wiener et al. | Jan 2011 | A1 |
20110015660 | Wiener et al. | Jan 2011 | A1 |
20110082486 | Messerly et al. | Apr 2011 | A1 |
20110087212 | Aldridge et al. | Apr 2011 | A1 |
20110087213 | Messerly et al. | Apr 2011 | A1 |
20110087214 | Giordano et al. | Apr 2011 | A1 |
20110087215 | Aldridge et al. | Apr 2011 | A1 |
20110087216 | Aldridge et al. | Apr 2011 | A1 |
20110087217 | Yates et al. | Apr 2011 | A1 |
20110087218 | Boudreaux et al. | Apr 2011 | A1 |
20110087256 | Wiener et al. | Apr 2011 | A1 |
20110125175 | Stulen et al. | May 2011 | A1 |
20110196286 | Robertson et al. | Aug 2011 | A1 |
20110196287 | Robertson et al. | Aug 2011 | A1 |
20110196398 | Robertson et al. | Aug 2011 | A1 |
20110196399 | Robertson et al. | Aug 2011 | A1 |
20110196400 | Robertson et al. | Aug 2011 | A1 |
20110196401 | Robertson et al. | Aug 2011 | A1 |
20110196402 | Robertson et al. | Aug 2011 | A1 |
20110196403 | Robertson et al. | Aug 2011 | A1 |
20110196404 | Dietz et al. | Aug 2011 | A1 |
20110196405 | Dietz | Aug 2011 | A1 |
20110288452 | Houser et al. | Nov 2011 | A1 |
20120029546 | Robertson | Feb 2012 | A1 |
20120059289 | Nield et al. | Mar 2012 | A1 |
20120078139 | Aldridge et al. | Mar 2012 | A1 |
20120078247 | Worrell et al. | Mar 2012 | A1 |
20120083783 | Davison et al. | Apr 2012 | A1 |
20120083784 | Davison et al. | Apr 2012 | A1 |
20120184946 | Price et al. | Jul 2012 | A1 |
20120203257 | Stulen et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
1634601 | Jul 2005 | CN |
1640365 | Jul 2005 | CN |
1694649 | Nov 2005 | CN |
1922563 | Feb 2007 | CN |
101040799 | Sep 2007 | CN |
0171967 | Feb 1986 | EP |
0443256 | Aug 1991 | EP |
0456470 | Nov 1991 | EP |
0482195 | Apr 1992 | EP |
0482195 | Jan 1996 | EP |
0612570 | Jun 1997 | EP |
0908148 | Jan 2002 | EP |
0908155 | Jun 2003 | EP |
1199044 | Dec 2005 | EP |
1433425 | Jun 2006 | EP |
1844720 | Oct 2007 | EP |
1862133 | Dec 2007 | EP |
1974771 | Oct 2008 | EP |
1832259 | Jun 2009 | EP |
2074959 | Jul 2009 | EP |
2032221 | Apr 1980 | GB |
2447767 | Aug 2011 | GB |
6-104503 | Apr 1994 | JP |
8-24266 | Jan 1996 | JP |
10-295700 | Nov 1998 | JP |
2005027026 | Jan 2005 | JP |
2006217716 | Aug 2006 | JP |
WO 9222259 | Dec 1992 | WO |
WO 9314708 | Aug 1993 | WO |
WO 9837815 | Sep 1998 | WO |
WO 0154590 | Aug 2001 | WO |
WO 2005122917 | Dec 2005 | WO |
WO 2006042210 | Apr 2006 | WO |
WO 2006058223 | Jun 2006 | WO |
WO 2006129465 | Dec 2006 | WO |
WO 2007008710 | Jan 2007 | WO |
WO 2007047531 | Apr 2007 | WO |
WO 2007143665 | Dec 2007 | WO |
WO 2008016886 | Feb 2008 | WO |
WO 2008130793 | Oct 2008 | WO |
WO 2009018406 | Feb 2009 | WO |
WO 2009027065 | Mar 2009 | WO |
WO 2011144911 | Nov 2011 | WO |
Entry |
---|
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (date unknown). |
U.S. Appl. No. 11/881,636, filed Jul. 27, 2007. |
International Search Report for PCT/US2008/070983, Nov. 7, 2008 (5 pages). |
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages). |
U.S. Appl. No. 12/181,816, filed Jul. 29, 2008. |
U.S. Appl. No. 11/881,602, filed Jul. 27, 2007. |
U.S. Appl. No. 11/888,081, filed Jul. 31, 2007. |
U.S. Appl. No. 11/881,654, filed Jul. 27, 2007. |
U.S. Appl. No. 11/888,171, filed Jul. 31, 2007. |
U.S. Appl. No. 11/998,758, filed Nov. 30, 2007. |
U.S. Appl. No. 11/881,662, filed Jul. 27, 2007. |
U.S. Appl. No. 11/888,222, filed Jul. 31, 2007. |
U.S. Appl. No. 12/245,158, filed Oct. 3, 2008. |
U.S. Appl. No. 29/292,295, filed Oct. 5, 2007. |
U.S. Appl. No. 11/998,543, filed Nov. 30, 2007. |
U.S. Appl. No. 29/327,737, filed Nov. 12, 2008. |
U.S. Appl. No. 12/274,884, filed Nov. 20, 2008. |
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages). |
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002. |
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003). |
U.S. Appl. No. 12/469,293, filed May 20, 2009. |
U.S. Appl. No. 12/469,308, filed May 20, 2009. |
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006). |
U.S. Appl. No. 12/503,769, filed Jul. 15, 2009. |
U.S. Appl. No. 12/503,770, filed Jul. 15, 2009. |
U.S. Appl. No. 12/503,766, filed Jul. 15, 2009. |
U.S. Appl. No. 12/490,906, filed Jun. 24, 2009. |
U.S. Appl. No. 12/490,922, filed Jun. 24, 2009. |
U.S. Appl. No. 12/490,933, filed Jun. 24, 2009. |
U.S. Appl. No. 12/490,948, filed Jun. 24, 2009. |
U.S. Appl. No. 12/703,860, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,864, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,866, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,870, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,875, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,877, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,879, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,885, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,893, filed Feb. 11, 2010. |
U.S. Appl. No. 12/703,899, filed Feb. 11, 2010. |
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973). |
Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). (Book—not attached). |
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990). |
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995). |
Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008). |
U.S. Appl. No. 12/896,351, filed Oct. 1, 2010. |
U.S. Appl. No. 12/896,411, filed Oct. 1, 2010. |
U.S. Appl. No. 12/896,420, filed Oct. 1, 2010. |
U.S. Appl. No. 29/402,697, filed Sep. 26, 2011. |
U.S. Appl. No. 29/402,699, filed Sep. 26, 2011. |
U.S. Appl. No. 29/402,700, filed Sep. 26, 2011. |
U.S. Appl. No. 29/402,701, filed Sep. 26, 2011. |
U.S. Appl. No. 13/251,766, filed Oct. 3, 2011. |
U.S. Appl. No. 29/404,676, filed Oct. 24, 2011. |
U.S. Appl. No. 13/296,829, filed Nov. 15, 2011. |
U.S. Appl. No. 13/448,175, filed Apr. 16, 2012. |
U.S. Appl. No. 13/151,181, filed Jun. 2, 2011. |
U.S. Appl. No. 13/369,561, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,569, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,578, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,584, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,588, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,594, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,601, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,609, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,629, filed Feb. 9, 2012. |
U.S. Appl. No. 13/369,666, filed Feb. 9, 2012. |
U.S. Appl. No. 13/545,292, filed Jul. 10, 2012. |
U.S. Appl. No. 13/584,020, filed Aug. 13, 2012. |
U.S. Appl. No. 13/584,445, filed Aug. 13, 2012. |
U.S. Appl. No. 13/584,878, filed Aug. 14, 2012. |
U.S. Appl. No. 13/585,124, filed Aug. 14, 2012. |
U.S. Appl. No. 13/585,292, filed Aug. 14, 2012. |
Number | Date | Country | |
---|---|---|---|
20090030439 A1 | Jan 2009 | US |